The medication is best known by Novo Nordisk's brand names Ozempic (approved for type 2 diabetes) and Wegovy (approved for obesity), which are both glucagon-like peptide-1 inhibitors (GLP-1s). RELATED ...
Some results have been hidden because they may be inaccessible to you